Bayer Archives - CFO

Elanco to Buy Bayer Animal Health Unit for $7.6B

Elanco to Buy Bayer Animal Health Unit for $7.6B

The deal would make Elanco the second biggest animal health business in the world.

By Lauren Muskett | August 20, 2019

Bayer to Shed Assets, Cut Jobs Amid Share Pressure

Bayer to Shed Assets, Cut Jobs Amid Share Pressure

It's a broad restructuring of the German conglomerate, which plans to sell its sun-care and foot care businesses and exit its animal health division.

By William Sprouse | November 29, 2018

Monsanto Cancer Verdict Rattles Bayer Shares

Risk & Compliance

Monsanto Cancer Verdict Rattles Bayer Shares

Analysts warn Bayer could face a "litigious headache" after the $289 million jury award in a product liability case over Monsanto's Roundup pesticide.

By Matthew Heller | August 14, 2018

Monsanto Misses Estimates on Corn Slowdown

Financial Performance

Monsanto Misses Estimates on Corn Slowdown

"Despite tough farm economics, we delivered a solid second quarter and are staying disciplined on near-term execution of the business," CEO Hugh Grant says.

By Matthew Heller | April 5, 2018

BASF to Buy Bayer Seed Businesses for $6.9B

BASF to Buy Bayer Seed Businesses for $6.9B

The deal may help clear the way for European authorities to approve Bayer's acquisition of Monsanto early next year.

By Matthew Heller | October 13, 2017

Free from Bayer, Covestro Finally Can Build for the Future

Free from Bayer, Covestro Finally Can Build for the Future

The spun-off materials science company had to build out most functions from scratch but has seen surprising early business results.

By David McCann | May 4, 2017

Bayer Clinches Monsanto Takeover for $66B

Bayer Clinches Monsanto Takeover for $66B

The deal continues the wave of consolidation in agribusiness, pairing Bayer's strength in crop chemicals with Monsanto's portfolio of seed products.

By Matthew Heller | September 14, 2016

The Year of Dealing Dangerously

The Year of Dealing Dangerously

Antitrust actions, buyer cautiousness, and longer due diligence phases have all contributed to a slowdown in mergers and acquisitions.

By Vincent Ryan | July 14, 2016

Bayer Discloses $62B Offer for Monsanto

Bayer Discloses $62B Offer for Monsanto

The deal would create the world's largest agricultural supplier but Bayer shareholders fear it will be detrimental to its pharmaceutical business

By Katie Kuehner-Hebert | May 23, 2016

Health Care: Things are Looking App

Health Care: Things are Looking App

Mobile health apps are becoming more capable and potentially rather useful.

By Economist Staff | March 14, 2016